The company specializes in developing, producing, and selling rapid diagnostic reagents and related equipment for in-vitro diagnostics. They have obtained CE certification from the European Union and ISO13485 quality management system certification. Wuhan Mingde Biotechnology focuses on various areas including cardiovascular and cerebrovascular diseases, infectious diseases, kidney disease, diabetes, health checkups, and obstetrics and gynaecology. Their product offerings include automatic immunoassay analyzers, mobile ECG machines, saccharification analyzers, chemiluminescence reagents, blood gas products, and molecular diagnostic reagents.